Reported covered position: Paid Intern, Senator Don Nickles ; ; Legislative Correspondant, Senator Don Nickles ; ; Scheduler, Senator Don Nickles ; ; Health Policy Director, Senator Don Nickles ; ; Deputy Assistant Secretary ASL, DHHS ; ; Special Assistant to the President, White House ; ; Senior Policy Advisor, Senator Mitch McConnell
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
Restore Protections for Dialysis Patients Act
Client: DAVITA INC. · Firm: RED+BLUE STRATEGIES
H.R. 2199/S. 1173 - Restore Protections for Dialysis Patients Act - Issues related to Medicare Secondary Payer policies related to people with ESRD. Issues related to innovation-centered kidney care choices model. Issues related to hospice and dialysis.
Restore Protections for Dialysis Patients Act
Client: DAVITA INC. · Firm: RED+BLUE STRATEGIES
H.R. 2199/S. 1173 - Restore Protections for Dialysis Patients Act - Issues related to Medicare Secondary Payer policies related to people with ESRD. Issues related to innovation-centered kidney care choices model. Exclusion of skin substitute spend from PY 2025 Comprehensive Kidney Care Contracting (CKCC) Kidney Care Entities (KCE) benchmarks.
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
HIMS&HERS via RED+BLUE STRATEGIES
2026 · third_quarter · Q3
Issues related to compounding/telehealth/health care.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
FOUNTAIN HOUSE via RED+BLUE STRATEGIES
2026 · third_quarter · Q3
Source: Senate LDA
| CAREFIRST BLUECROSS BLUESHIELD | 49 | 2015–2026 |
| GE HEALTHCARE | 44 | 2011–2026 |
| PEW CHARITABLE TRUSTS | 44 | 2011–2021 |
| BOSTON MEDICAL CENTER | 40 | 2017–2026 |
| THE GUARDIAN LIFE INSURANCE COMPANY OF AMERICA | 35 | 2018–2026 |
| BAYCARE HEALTH SYSTEM | 34 | 2019–2026 |
| COHERUS BIOSCIENCES | 34 | 2015–2023 |
| EXPRESS SCRIPTS INC | 34 | 2011–2018 |
| QUEST DIAGNOSTICS INCORPORATED | 33 | 2018–2026 |
| MONTEFIORE MEDICAL CENTER | 18 | 2013–2017 |
| AMERICAN SOCIETY FROM RADIATION ONCOLOGY (ASTRO) | 16 | 2016–2020 |
| FREELANCERS UNION | 14 | 2011–2014 |
| AMERICAN HOSPITAL ASSOCIATION | 8 | 2025–2026 |
| COMMONWEALTH CARE ALLIANCE | 8 | 2016–2017 |
| GENEDX, LLC | 8 | 2025–2026 |
| GREATER NEW YORK HOSPITAL ASSOCIATION | 8 | 2025–2026 |
| ARCHER AVIATION | 7 | 2025–2026 |
| HPA MANAGEMENT GROUP INC. | 7 | 2025–2026 |
| MOUNT SINAI HOSPITALS GROUP, INC | 7 | 2025–2026 |
| CIGNA CORPORATION | 6 | 2019 |
| HOSPIRA | 6 | 2014–2015 |
| KAROO HEALTH | 6 | 2025–2026 |
| MCGOVERN AND ASSOCIATES | 6 | 2013–2014 |
| WILLS EYE HOSPITAL | 6 | 2018–2019 |
| FREELANCERS INSURANCE COMPANY | 5 | 2013 |
| INDEPENDENT WORKERS SERVICES | 5 | 2013 |
| CHAPTER | 4 | 2026 |
| PALANTIR TECHNOLOGIES, INC. | 4 | 2026 |
| VIRTUS PHARMACEUTICALS | 4 | 2016 |
| THE CIGNA GROUP | 3 | 2026 |
| FOUNTAIN HOUSE | 2 | 2026 |
| HIMS&HERS | 2 | 2026 |
| PRIME THERAPEUTICS | 2 | 2026 |
Restore Protections for Dialysis Patients Act
Client: DAVITA INC. · Firm: RED+BLUE STRATEGIES
H.R. 2199/S. 1173 - Restore Protections for Dialysis Patients Act - Issues related to Medicare Secondary Payer policies related to people with ESRD. Issues related to innovation-centered kidney care choices model. Exclusion of skin substitute spend from PY 2025 Comprehensive Kidney Care Contracting (CKCC) Kidney Care Entities (KCE) benchmarks.
Hospital Inpatient Services Modernization Act
Client: BAYCARE HEALTH SYSTEM · Firm: RED+BLUE STRATEGIES
Issues related to the Medicare Hospital at Home program. H.R.4313 - Hospital Inpatient Services Modernization Act - issues related to the hospital care at home. Monitor proposals related to NIH's calculation of indirect costs. H.R. 7148 - Consolidated Appropriations Act, 2026 - issues related to agencies supporting health care research in the U.S
Newborn Screening Saves Lives Reauthorization Act of 2025
Client: GENEDX, LLC · Firm: RED+BLUE STRATEGIES
H. R. 4709 - Newborn Screening Saves Lives Act of 2025 - Support for advancing 21st century genetic screenings protocols for newborns and their families. Issues related to access and affordability for pediatric genetic tests for children and families nationwide. H.R. 5269 - RESULTS Act - issues related to Medicare payments for lab tests. S. 2761 - RESULTS Act - issues related to Medicare payments for lab tests.
Newborn Screening Saves Lives Reauthorization Act of 2025
Client: GENEDX, LLC · Firm: RED+BLUE STRATEGIES
H. R. 4709 - Newborn Screening Saves Lives Act of 2025 - Support for advancing 21st century genetic screenings protocols for newborns and their families. Issues related to access and affordability for pediatric genetic tests for children and families nationwide. H.R. 5269 - RESULTS Act - issues related to Medicare payments for lab tests. S. 2761 - RESULTS Act - issues related to Medicare payments for lab tests.
Newborn Screening Saves Lives Reauthorization Act of 2025
Client: GENEDX, LLC · Firm: RED+BLUE STRATEGIES
H. R. 4709 - Newborn Screening Saves Lives Act of 2025 - Support for advancing 21st century genetic screenings protocols for newborns and their families. Issues related to access and affordability for pediatric genetic tests for children and families nationwide.
Policies, rules, and regulations related to clinical laboratories and Medicare coverage policies. H.R.5269 - Reforming and Enhancing Sustainable Updates to Laboratory Testing Services (RESULTS) Act - Issues related to Medicare payments for lab tests. S.2761 - RESULTS Act - Issues related to Medicare payments for lab tests. H.R. 7148 - Consolidated Appropriations Act, 2026 - issues related to clinical lab test reimbursement rates.
Policies, rules, and regulations related to clinical laboratories and Medicare coverage policies. H.R.5269 - Reforming and Enhancing Sustainable Updates to Laboratory Testing Services (RESULTS) Act - Issues related to Medicare payments for lab tests. S.2761 - RESULTS Act - Issues related to Medicare payments for lab tests.
Policies, rules, and regulations related to clinical laboratories and Medicare coverage policies. H.R.5269 - Reforming and Enhancing Sustainable Updates to Laboratory Testing Services (RESULTS) Act - Issues related to Medicare payments for lab tests. S.2761 - RESULTS Act - Issues related to Medicare payments for lab tests.
H. R. 4709 - Newborn Screening Saves Lives Act of 2025 - Support for advancing 21st century genetic screenings protocols for newborns and their families. Issues related to access and affordability for pediatric genetic tests for children and families nationwide. H.R. 5269 - RESULTS Act - issues related to Medicare payments for lab tests. S. 2761 - RESULTS Act - issues related to Medicare payments for lab tests.
H. R. 4709 - Newborn Screening Saves Lives Act of 2025 - Support for advancing 21st century genetic screenings protocols for newborns and their families. Issues related to access and affordability for pediatric genetic tests for children and families nationwide. H.R. 5269 - RESULTS Act - issues related to Medicare payments for lab tests. S. 2761 - RESULTS Act - issues related to Medicare payments for lab tests.
Genomic Answers for Children’s Health Act of 2026
Client: GENEDX, LLC · Firm: RED+BLUE STRATEGIES
Issues related to access and affordability for pediatric genetic tests for families with Medicaid and Marketplace coverage. Issues related to the FY27 Labor-HHS appropriations process - highlighting Genetic Testing Guidance for State Medicaid Programs report language. H.R. 7118 - Genomic Answers for Children's Health Act of 2026 - support for clarifying access to genomic sequencing for children enrolled in Medicaid who have a suspected rare disease or genetic disorder.
Genomic Answers for Children’s Health Act of 2026
Client: GENEDX, LLC · Firm: RED+BLUE STRATEGIES
Issues related to access and affordability for pediatric genetic tests for families with Medicaid and Marketplace coverage. Issues related to the FY27 Labor-HHS appropriations process - highlighting Genetic Testing Guidance for State Medicaid Programs report language. H.R. 7118 - Genomic Answers for Children's Health Act of 2026 - support for clarifying access to genomic sequencing for children enrolled in Medicaid who have a suspected rare disease or genetic disorder
Genomic Answers for Children’s Health Act of 2026
Client: GENEDX, LLC · Firm: RED+BLUE STRATEGIES
Issues related to access and affordability for pediatric genetic tests for families with Medicaid and Marketplace coverage. Issues related to the FY27 Labor-HHS appropriations process - highlighting Genetic Testing Guidance for State Medicaid Programs report language. H.R. 7118 - Genomic Answers for Children's Health Act of 2026 - support for clarifying access to genomic sequencing for children enrolled in Medicaid who have a suspected rare disease or genetic disorder
Consolidated Appropriations Act, 2026
Client: MOUNT SINAI HOSPITALS GROUP, INC · Firm: RED+BLUE STRATEGIES
Rules and regulations governing Medicare, Medicaid, Marketplace and other public insurance programs covering patient access to care. Issues related to the Essential Plan. Monitor proposals related to NIH's calculation of indirect costs. H.R. 7148 - Consolidated Appropriations Act, 2026 - issues related to agencies supporting health care research in the U.S. Issues related to Federally Qualified Health Centers (FQHCs).
Consolidated Appropriations Act, 2026
Client: CHILDREN'S HOSPITAL ASSOCIATION F/K/A NAT'L ASSOCIATION OF CHILDREN'S HOSPITALS · Firm: RED+BLUE STRATEGIES
Regulatory issues related to Medicaid and CHIP. Regulatory issues related to the Children's Hospitals Graduate Medical Education Program. Monitor proposals related to NIH's calculation of indirect costs. H.R. 7148 - Consolidated Appropriations Act, 2026 - issues related to funding of agencies and programs related to children's health care. Issues related to the FY27 Labor-HHS appropriations process - highlighting the Childrens Hospital Graduate Medical Education (CHGME) program and the Pediatric Specialty Loan Repayment Program.
Consolidated Appropriations Act, 2026
Client: BOSTON MEDICAL CENTER · Firm: RED+BLUE STRATEGIES
Regulatory issues related to Medicaid and CHIP. H.R. 7148 - Consolidated Appropriations Act, 2026 - issues related to agencies supporting health care research in the U.S.
Consolidated Appropriations Act, 2026
Client: PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION (PCMA) · Firm: RED+BLUE STRATEGIES
Issues related to pharmacy benefit managers and their role in public and private insurance coverage. H.R. 7148 - Consolidated Appropriations Act, 2026 - issues related to pharmacy benefit managers.
Consolidated Appropriations Act, 2026
Client: QUEST DIAGNOSTICS INCORPORATED · Firm: RED+BLUE STRATEGIES
Policies, rules, and regulations related to clinical laboratories and Medicare coverage policies. H.R.5269 - Reforming and Enhancing Sustainable Updates to Laboratory Testing Services (RESULTS) Act - Issues related to Medicare payments for lab tests. S.2761 - RESULTS Act - Issues related to Medicare payments for lab tests. H.R. 7148 - Consolidated Appropriations Act, 2026 - issues related to clinical lab test reimbursement rates.
Consolidated Appropriations Act, 2026
Client: GREATER NEW YORK HOSPITAL ASSOCIATION · Firm: RED+BLUE STRATEGIES
Policies, rules, and regulations related to Medicaid, Medicare, Essential and Marketplace coverage. Issues related to the Essential Plan. Monitor proposals related to NIH's calculation of indirect costs. Issues related to graduate medical education (GME) slots. H.R. 7148 - Consolidated Appropriations Act, 2026 - issues related to agencies supporting health care research in the U.S.
Consolidated Appropriations Act, 2026
Client: BAYCARE HEALTH SYSTEM · Firm: RED+BLUE STRATEGIES
Issues related to the Medicare Hospital at Home program. H.R.4313 - Hospital Inpatient Services Modernization Act - issues related to the hospital care at home. Monitor proposals related to NIH's calculation of indirect costs. H.R. 7148 - Consolidated Appropriations Act, 2026 - issues related to agencies supporting health care research in the U.S
Consolidated Appropriations Act, 2026
Client: BOSTON MEDICAL CENTER · Firm: RED+BLUE STRATEGIES
Regulatory issues related to ACA Marketplaces, Medicaid and CHIP. Regulatory issues related to health care research. Monitor proposals relating to NIH's calculation of indirect costs. H.R. 7148 - Consolidated Appropriations Act, 2026 - issues related to agencies supporting health care research in the U.S.
H–1Bs for Physicians and the Healthcare Workforce Act
Client: GREATER NEW YORK HOSPITAL ASSOCIATION · Firm: RED+BLUE STRATEGIES
HR 7961 - Issues related to waiving the application fee for H-1B visas for foreign health care professionals seeking to work in the United States
H–1Bs for Physicians and the Healthcare Workforce Act
Client: MOUNT SINAI HOSPITALS GROUP, INC · Firm: RED+BLUE STRATEGIES
HR 7961 - Issues related to waiving the application fee for H-1B visas for foreign health care professionals seeking to work in the United States.
H–1Bs for Physicians and the Healthcare Workforce Act
Client: GREATER NEW YORK HOSPITAL ASSOCIATION · Firm: RED+BLUE STRATEGIES
HR 7961 - Issues related to waiving the application fee for H-1B visas for foreign health care professionals seeking to work in the United States
H–1Bs for Physicians and the Healthcare Workforce Act
Client: GREATER NEW YORK HOSPITAL ASSOCIATION · Firm: RED+BLUE STRATEGIES
HR 7961 - Issues related to waiving the application fee for H-1B visas for foreign health care professionals seeking to work in the United States.
H–1Bs for Physicians and the Healthcare Workforce Act
Client: MOUNT SINAI HOSPITALS GROUP, INC · Firm: RED+BLUE STRATEGIES
HR 7961 - Issues related to waiving the application fee for H-1B visas for foreign health care professionals seeking to work in the United States.
H–1Bs for Physicians and the Healthcare Workforce Act
Client: MOUNT SINAI HOSPITALS GROUP, INC · Firm: RED+BLUE STRATEGIES
HR 7961 - Issues related to waiving the application fee for H-1B visas for foreign health care professionals seeking to work in the United States.
Issues related to the Medicare Hospital at Home program H.R.8923 - At HOME Services Act - issues related to hospital care at home Monitor issues and proposals related to health care price transparency Issues related to organ transplantation
Issues related to the Medicare Hospital at Home program H.R.8923 - At HOME Services Act - issues related to hospital care at home Monitor issues and proposals related to health care price transparency Monitoring H.R. 9504 - Tax Exempt Hospital Transparency Act - issues related to hospital reporting requirements
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2027
Client: BOSTON MEDICAL CENTER · Firm: RED+BLUE STRATEGIES
Regulatory issues related to ACA Marketplaces, Medicaid and CHIP. Regulatory issues related to health care research. H.R. 9260 - FY27 Depts. of Labor, HHS, Education Appropriations - and Senate FY27 Labor-HHS appropriations process - highlighting Hospital at Home report language.
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2027
Client: BAYCARE HEALTH SYSTEM · Firm: RED+BLUE STRATEGIES
Issues related to the Medicare Hospital at Home program. H.R. 9260 - FY27 Depts. of Labor, HHS, Education Appropriations - and Senate FY27 Labor-HHS appropriations process - highlighting Hospital at Home report language.
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2027
Client: BOSTON MEDICAL CENTER · Firm: RED+BLUE STRATEGIES
Regulatory issues related to ACA Marketplaces, Medicaid and CHIP. Regulatory issues related to health care research. H.R. 9260 - FY27 Depts. of Labor, HHS, Education Appropriations - and Senate FY27 Labor-HHS appropriations process - highlighting Hospital at Home report language.
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2027
Client: BAYCARE HEALTH SYSTEM · Firm: RED+BLUE STRATEGIES
Issues related to the Medicare Hospital at Home program. H.R. 9260 - FY27 Depts. of Labor, HHS, Education Appropriations - and Senate FY27 Labor-HHS appropriations process - highlighting Hospital at Home report language.
Tax Exempt Hospital Transparency Act
Client: MOUNT SINAI HOSPITALS GROUP, INC · Firm: RED+BLUE STRATEGIES
Rules and regulations governing Medicare, Medicaid, Marketplace and other public insurance programs covering patient access to care. Issues related to the Essential Plan. Monitoring H.R. 9504 - Tax Exempt Hospital Transparency Act - issues related to hospital reporting requirements Monitor issues and proposals related to health care price transparency
Tax Exempt Hospital Transparency Act
Client: CHILDREN'S HOSPITAL ASSOCIATION F/K/A NAT'L ASSOCIATION OF CHILDREN'S HOSPITALS · Firm: RED+BLUE STRATEGIES
Regulatory issues related to Medicaid and CHIP. Regulatory issues related to the Children's Hospitals Graduate Medical Education Program. Issues related to the FY27 Labor-HHS appropriations process - highlighting the Childrens Hospital Graduate Medical Education (CHGME) program and the Pediatric Specialty Loan Repayment Program. Monitoring H.R. 9504 - Tax Exempt Hospital Transparency Act - issues related to hospital reporting requirements. Issues related to CMS' State-Directed Payment Rule. Issues related to CMS' Inpatient Prospective Payment System (IPPS) Rule.
Tax Exempt Hospital Transparency Act
Client: AMERICAN HOSPITAL ASSOCIATION · Firm: RED+BLUE STRATEGIES
Policies, rules, and regulations related to Medicaid, Medicare, Essential and Marketplace coverage. Monitoring H.R. 9504 - Tax Exempt Hospital Transparency Act - issues related to hospital reporting requirements.
Tax Exempt Hospital Transparency Act
Client: BAYCARE HEALTH SYSTEM · Firm: RED+BLUE STRATEGIES
Issues related to the Medicare Hospital at Home program H.R.8923 - At HOME Services Act - issues related to hospital care at home Monitor issues and proposals related to health care price transparency Monitoring H.R. 9504 - Tax Exempt Hospital Transparency Act - issues related to hospital reporting requirements
Tax Exempt Hospital Transparency Act
Client: GREATER NEW YORK HOSPITAL ASSOCIATION · Firm: RED+BLUE STRATEGIES
Policies, rules, and regulations related to Medicaid, Medicare, Essential and Marketplace coverage. Issues related to the Essential Plan. Issues related to graduate medical education (GME) slots. Monitoring H.R. 9504 - Tax Exempt Hospital Transparency Act - issues related to hospital reporting requirements.
Regulatory issues related to Medicaid and CHIP. Monitor issues related to 340B, including H.R.9599 - SECURE 340B Act.
H.R. 2199/S. 1173 - Restore Protections for Dialysis Patients Act - Issues related to Medicare Secondary Payer policies related to people with ESRD. Issues related to innovation-centered kidney care choices model. Issues related to hospice and dialysis.
H.R. 2199/S. 1173 - Restore Protections for Dialysis Patients Act - Issues related to Medicare Secondary Payer policies related to people with ESRD. Issues related to innovation-centered kidney care choices model. Exclusion of skin substitute spend from PY 2025 Comprehensive Kidney Care Contracting (CKCC) Kidney Care Entities (KCE) benchmarks.
H.R. 2199/S. 1173 - Restore Protections for Dialysis Patients Act - Issues related to Medicare Secondary Payer policies related to people with ESRD. Issues related to innovation-centered kidney care choices model. Exclusion of skin substitute spend from PY 2025 Comprehensive Kidney Care Contracting (CKCC) Kidney Care Entities (KCE) benchmarks.
H. R. 4709 - Newborn Screening Saves Lives Act of 2025 - Support for advancing 21st century genetic screenings protocols for newborns and their families. Issues related to access and affordability for pediatric genetic tests for children and families nationwide. H.R. 5269 - RESULTS Act - issues related to Medicare payments for lab tests. S. 2761 - RESULTS Act - issues related to Medicare payments for lab tests.
Policies, rules, and regulations related to clinical laboratories and Medicare coverage policies. H.R.5269 - Reforming and Enhancing Sustainable Updates to Laboratory Testing Services (RESULTS) Act - Issues related to Medicare payments for lab tests. S.2761 - RESULTS Act - Issues related to Medicare payments for lab tests. H.R. 7148 - Consolidated Appropriations Act, 2026 - issues related to clinical lab test reimbursement rates.
Policies, rules, and regulations related to clinical laboratories and Medicare coverage policies. H.R.5269 - Reforming and Enhancing Sustainable Updates to Laboratory Testing Services (RESULTS) Act - Issues related to Medicare payments for lab tests. S.2761 - RESULTS Act - Issues related to Medicare payments for lab tests.
Policies, rules, and regulations related to clinical laboratories and Medicare coverage policies. H.R.5269 - Reforming and Enhancing Sustainable Updates to Laboratory Testing Services (RESULTS) Act - Issues related to Medicare payments for lab tests. S.2761 - RESULTS Act - Issues related to Medicare payments for lab tests.
H. R. 4709 - Newborn Screening Saves Lives Act of 2025 - Support for advancing 21st century genetic screenings protocols for newborns and their families. Issues related to access and affordability for pediatric genetic tests for children and families nationwide. H.R. 5269 - RESULTS Act - issues related to Medicare payments for lab tests. S. 2761 - RESULTS Act - issues related to Medicare payments for lab tests.
Future in Logging Careers Act
Client: THE GUARDIAN LIFE INSURANCE COMPANY OF AMERICA · Firm: RED+BLUE STRATEGIES
H.R. 1397/S.1164 - Increasing Access to Dental Insurance Act of 2025 - Issues related to expanding access to quality dental care coverage to populations that require care. Regulatory issues impacting dental coverage issues in Medicare, Medicaid and Marketplace. H.R. 1521/S. 1424 (in 118th Congress - Senate reintroduction pending) - DOC Access Act - issues related to dental coverage.
Future in Logging Careers Act
Client: THE GUARDIAN LIFE INSURANCE COMPANY OF AMERICA · Firm: RED+BLUE STRATEGIES
H.R. 1397/S.1164 - Increasing Access to Dental Insurance Act of 2025 - Issues related to expanding access to quality dental care coverage to populations that require care. Regulatory issues impacting dental coverage issues in Medicare, Medicaid and Marketplace. H.R. 1521/S. 1424 (in 118th Congress - Senate reintroduction pending) - DOC Access Act - issues related to dental coverage.
Future in Logging Careers Act
Client: THE GUARDIAN LIFE INSURANCE COMPANY OF AMERICA · Firm: RED+BLUE STRATEGIES
H.R. 1397/S.1164 - Increasing Access to Dental Insurance Act of 2025 - Issues related to expanding access to quality dental care coverage to populations that require care. Regulatory issues impacting dental coverage issues in Medicare, Medicaid and Marketplace. H.R. 1521/S. 1424 (in 118th Congress - Senate reintroduction pending) - DOC Access Act - issues related to dental coverage.
Servicemember Credit Monitoring Enhancement Act
Client: THE GUARDIAN LIFE INSURANCE COMPANY OF AMERICA · Firm: RED+BLUE STRATEGIES
H.R. 1397/S.1164 - Increasing Access to Dental Insurance Act of 2025 - Issues related to expanding access to quality dental care coverage to populations that require care. Regulatory issues impacting dental coverage issues in Medicare, Medicaid and Marketplace. H.R. 1521/S. 1424 (in 118th Congress - Senate reintroduction pending) - DOC Access Act - issues related to dental coverage.
Servicemember Credit Monitoring Enhancement Act
Client: THE GUARDIAN LIFE INSURANCE COMPANY OF AMERICA · Firm: RED+BLUE STRATEGIES
H.R. 1397/S.1164 - Increasing Access to Dental Insurance Act of 2025 - Issues related to expanding access to quality dental care coverage to populations that require care. Regulatory issues impacting dental coverage issues in Medicare, Medicaid and Marketplace. H.R. 1521/S. 1424 (in 118th Congress - Senate reintroduction pending) - DOC Access Act - issues related to dental coverage.
Servicemember Credit Monitoring Enhancement Act
Client: THE GUARDIAN LIFE INSURANCE COMPANY OF AMERICA · Firm: RED+BLUE STRATEGIES
H.R. 1397/S.1164 - Increasing Access to Dental Insurance Act of 2025 - Issues related to expanding access to quality dental care coverage to populations that require care. Regulatory issues impacting dental coverage issues in Medicare, Medicaid and Marketplace. H.R. 1521/S. 1424 (in 118th Congress - Senate reintroduction pending) - DOC Access Act - issues related to dental coverage.
Seedlings for Sustainable Habitat Restoration Act of 2023
Client: THE GUARDIAN LIFE INSURANCE COMPANY OF AMERICA · Firm: RED+BLUE STRATEGIES
H.R. 1397/S.1164 - Increasing Access to Dental Insurance Act of 2025 - Issues related to expanding access to quality dental care coverage to populations that require care. Regulatory issues impacting dental coverage issues in Medicare, Medicaid and Marketplace. H.R. 1521/S. 1424 (in 118th Congress - Senate reintroduction pending) - DOC Access Act - issues related to dental coverage.
Seedlings for Sustainable Habitat Restoration Act of 2023
Client: THE GUARDIAN LIFE INSURANCE COMPANY OF AMERICA · Firm: RED+BLUE STRATEGIES
H.R. 1397/S.1164 - Increasing Access to Dental Insurance Act of 2025 - Issues related to expanding access to quality dental care coverage to populations that require care. Regulatory issues impacting dental coverage issues in Medicare, Medicaid and Marketplace. H.R. 1521/S. 1424 (in 118th Congress - Senate reintroduction pending) - DOC Access Act - issues related to dental coverage.
Seedlings for Sustainable Habitat Restoration Act of 2023
Client: THE GUARDIAN LIFE INSURANCE COMPANY OF AMERICA · Firm: RED+BLUE STRATEGIES
H.R. 1397/S.1164 - Increasing Access to Dental Insurance Act of 2025 - Issues related to expanding access to quality dental care coverage to populations that require care. Regulatory issues impacting dental coverage issues in Medicare, Medicaid and Marketplace. H.R. 1521/S. 1424 (in 118th Congress - Senate reintroduction pending) - DOC Access Act - issues related to dental coverage.
DOC Access Act of 2023
Client: THE GUARDIAN LIFE INSURANCE COMPANY OF AMERICA · Firm: RED+BLUE STRATEGIES
H.R. 1397/S.1164 - Increasing Access to Dental Insurance Act of 2025 - Issues related to expanding access to quality dental care coverage to populations that require care. Regulatory issues impacting dental coverage issues in Medicare, Medicaid and Marketplace. H.R. 1521/S. 1424 (in 118th Congress - Senate reintroduction pending) - DOC Access Act - issues related to dental coverage.
DOC Access Act of 2023
Client: THE GUARDIAN LIFE INSURANCE COMPANY OF AMERICA · Firm: RED+BLUE STRATEGIES
H.R. 1397/S.1164 - Increasing Access to Dental Insurance Act of 2025 - Issues related to expanding access to quality dental care coverage to populations that require care. Regulatory issues impacting dental coverage issues in Medicare, Medicaid and Marketplace. H.R. 1521/S. 1424 (in 118th Congress - Senate reintroduction pending) - DOC Access Act - issues related to dental coverage.
DOC Access Act of 2023
Client: THE GUARDIAN LIFE INSURANCE COMPANY OF AMERICA · Firm: RED+BLUE STRATEGIES
H.R. 1397/S.1164 - Increasing Access to Dental Insurance Act of 2025 - Issues related to expanding access to quality dental care coverage to populations that require care. Regulatory issues impacting dental coverage issues in Medicare, Medicaid and Marketplace. H.R. 1521/S. 1424 (in 118th Congress - Senate reintroduction pending) - DOC Access Act - issues related to dental coverage.
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: CHILDREN'S HOSPITAL ASSOCIATION F/K/A NAT'L ASSOCIATION OF CHILDREN'S HOSPITALS · Firm: RED+BLUE STRATEGIES
H.R. 1 - One Big Beautiful Bill Act - Issues related to Medicaid and other provisions impacting children's health care Regulatory issues related to Medicaid and CHIP Regulatory issues related to the Children's Hospitals Graduate Medical Education Program
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: CHILDREN'S HOSPITAL ASSOCIATION F/K/A NAT'L ASSOCIATION OF CHILDREN'S HOSPITALS · Firm: RED+BLUE STRATEGIES
H.R. 1 - One Big Beautiful Bill Act - Issues related to Medicaid and other provisions impacting children's health care Regulatory issues related to Medicaid and CHIP
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: GENEDX, LLC · Firm: RED+BLUE STRATEGIES
H.R. 1 - The One Big Beautiful Bill Act - Issues realted to pediatric screening and testing. Issues related to access and affordability for pediatric genetic tests for families with Medicaid and Marketplace coverage.
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: BAYCARE HEALTH SYSTEM · Firm: RED+BLUE STRATEGIES
H.R. 1 - One Big Beautiful Bill Act - Issues related to Medicaid and policies impacting patients, providers and hospitals. Issues related to the Medicare Hospital at Home program
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: BAYCARE HEALTH SYSTEM · Firm: RED+BLUE STRATEGIES
H.R. 1 - One Big Beautiful Bill Act - Issues related to Medicaid and policies impacting patients, providers and hospitals. Issues related to the Medicare Hospital at Home program
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: GENEDX, LLC · Firm: RED+BLUE STRATEGIES
H.R. 1 - The One Big Beautiful Bill Act - Issues realted to pediatric screening and testing. H. R. 4709 - Newborn Screening Saves Lives Act of 2025 - Support for advancing 21st century genetic screenings protocols for newborns and their families. Issues related to access and affordability for pediatric genetic tests for children and families nationwide.
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: BOSTON MEDICAL CENTER · Firm: RED+BLUE STRATEGIES
H.R. 1 - One Big Beautiful Bill Act - Issues related to Medicaid and other provisions impacting health care for vulnerable populatons. Regulatory issues related to Medicaid and CHIP.
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: CHILDREN'S HOSPITAL ASSOCIATION F/K/A NAT'L ASSOCIATION OF CHILDREN'S HOSPITALS · Firm: RED+BLUE STRATEGIES
H.R. 1 - One Big Beautiful Bill Act - Issues related to Medicaid and other provisions impacting children's health care H.R. 5304 - Departments of Health and Human Services and Education and Related Agencies Appropriations Act of 2025-26 - Issues related to funding of agencies and programs related to childrens health care. S. 2587 - Departments of Health and Human Services and Education and Related Agencies Appropriations Act of 2025-26 - Issues related to funding of agencies and programs related to childrens health care. Regulatory issues related to Medicaid and CHIP Regulatory issues related to the Children's Hospitals Graduate Medical Education Program
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: GENEDX, LLC · Firm: RED+BLUE STRATEGIES
H.R. 1 - The One Big Beautiful Bill Act - Issues realted to pediatric screening and testing. Issues related to access and affordability for pediatric genetic tests.
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: GENEDX, LLC · Firm: RED+BLUE STRATEGIES
H.R. 1 - The One Big Beautiful Bill Act - Issues realted to pediatric screening and testing. Issues related to access and affordability for pediatric genetic tests.
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: GENEDX, LLC · Firm: RED+BLUE STRATEGIES
H.R. 1 - The One Big Beautiful Bill Act - Issues realted to pediatric screening and testing. Issues related to access and affordability for pediatric genetic tests.
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: GENEDX, LLC · Firm: RED+BLUE STRATEGIES
H.R. 1 - The One Big Beautiful Bill Act - Issues realted to pediatric screening and testing. Issues related to access and affordability for pediatric genetic tests.
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: AMERICAN HOSPITAL ASSOCIATION · Firm: RED+BLUE STRATEGIES
H.R. 1 - One Big Beautiful Bill Act - Issues related to Medicaid, Marketplace, Essential Plan and other issues impacting hospitals' ability to provide care for patients. Policies, rules, and regulations related to Medicaid, Medicare, Essential and Marketplace coverage.
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: GREATER NEW YORK HOSPITAL ASSOCIATION · Firm: RED+BLUE STRATEGIES
H.R. 1 - One Big Beautiful Bill Act - Issues related to Medicaid, Marketplace, Essential Plan and other issues impacting hospitals' ability to provide care for patients. Policies, rules, and regulations related to Medicaid, Medicare, Essential and Marketplace coverage.
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: GREATER NEW YORK HOSPITAL ASSOCIATION · Firm: RED+BLUE STRATEGIES
H.R. 1 - One Big Beautiful Bill Act - Issues related to Medicaid, Marketplace, Essential Plan and other issues impacting hospitals' ability to provide care for patients. Policies, rules, and regulations related to Medicaid, Medicare, Essential and Marketplace coverage.
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: QUEST DIAGNOSTICS INCORPORATED · Firm: RED+BLUE STRATEGIES
H.R. 1 - One Big Beautiful Bill Act - Issues related to Medicaid and other provisions impacting access to laboratory services for covered populations. Policies, rules, and regulations related to clinical laboratories and Medicare coverage policies.
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: BOSTON MEDICAL CENTER · Firm: RED+BLUE STRATEGIES
H.R. 1 - One Big Beautiful Bill Act - Issues related to Medicaid and other provisions impacting health care for vulnerable populatons. Regulatory issues related to Medicaid and CHIP. Regulatory issues related to health care research.
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: CAMBIA HEALTH SOLUTIONS (FORMERLY KNOWN AS THE REGENCE GROUP) · Firm: RED+BLUE STRATEGIES
H.R. 1 - One Big Beautiful Bill Act - Issues related to Marketplace coverage and other provisions impacting health care coverage and delivery Issues related to prior authorization Issues related to Medicare Advantage Issues related to the extension of Marketplace E-APTCs
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: BLUE CROSS BLUE SHIELD OF MASSACHUSETTS · Firm: RED+BLUE STRATEGIES
H.R. 1 - One Big Beautiful Bill Act - Issues related to Marketplace Coverage and other provisions impacting health care Regulatory issues related to Medicare Advantage and the ACA Marketplace Issues related to the Enhances APTCs for coverage in the health care Marketplace
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: CHILDREN'S HOSPITAL ASSOCIATION F/K/A NAT'L ASSOCIATION OF CHILDREN'S HOSPITALS · Firm: RED+BLUE STRATEGIES
H.R. 1 - One Big Beautiful Bill Act - Issues related to Medicaid and other provisions impacting children's health care Regulatory issues related to Medicaid and CHIP
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: BAYCARE HEALTH SYSTEM · Firm: RED+BLUE STRATEGIES
H.R. 1 - One Big Beautiful Bill Act - Issues related to Medicaid and policies impacting patients, providers and hospitals. Issues related to the Medicare Hospital at Home program
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: MOUNT SINAI HOSPITALS GROUP, INC · Firm: RED+BLUE STRATEGIES
H.R. 1 - The One Big Beautiful Bill Act - Issues related to Medicaid, Marketplace, BHP and Medicare policies impacting hospitals and related health care institutions.
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: BAYCARE HEALTH SYSTEM · Firm: RED+BLUE STRATEGIES
H.R. 1 - One Big Beautiful Bill Act - Issues related to Medicaid and policies impacting patients, providers and hospitals. Issues related to the Medicare Hospital at Home program
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: COMMUNITY CATALYST · Firm: RED+BLUE STRATEGIES
H.R. 1 - One Big Beautiful Bill Act - Issues related to Medicaid and other provisions impacting access to health care Regulatory issues related to Medicaid and CHIP Legislative and Regulatory issues related to medical debt Issues related to shoring up Medicaid and Marketplace coverage for families.
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: MOUNT SINAI HOSPITALS GROUP, INC · Firm: RED+BLUE STRATEGIES
H.R. 1 - The One Big Beautiful Bill Act - Issues related to Medicaid, Marketplace, BHP and Medicare policies impacting hospitals and related health care institutions.
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: GREATER NEW YORK HOSPITAL ASSOCIATION · Firm: RED+BLUE STRATEGIES
H.R. 1 - One Big Beautiful Bill Act - Issues related to Medicaid, Marketplace, Essential Plan and other issues impacting hospitals' ability to provide care for patients. Policies, rules, and regulations related to Medicaid, Medicare, Essential and Marketplace coverage.
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: CAMBIA HEALTH SOLUTIONS (FORMERLY KNOWN AS THE REGENCE GROUP) · Firm: RED+BLUE STRATEGIES
H.R. 1 - One Big Beautiful Bill Act - Issues related to Marketplace coverage and other provisions impacting health care coverage and delivery Issues related to prior authorization regulations for the Medicare Advantage program Issues related to Medicare Advantage regulatory changes and adjustments Issues related to the extension of ACA Marketplace E-APTCs
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: BAYCARE HEALTH SYSTEM · Firm: RED+BLUE STRATEGIES
H.R. 1 - One Big Beautiful Bill Act - Issues related to Medicaid and policies impacting patients, providers and hospitals. Issues related to the Medicare Hospital at Home program
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: BAYCARE HEALTH SYSTEM · Firm: RED+BLUE STRATEGIES
H.R. 1 - One Big Beautiful Bill Act - Issues related to Medicaid and policies impacting patients, providers and hospitals. Issues related to the Medicare Hospital at Home program
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: GREATER NEW YORK HOSPITAL ASSOCIATION · Firm: RED+BLUE STRATEGIES
H.R. 1 - One Big Beautiful Bill Act - Issues related to Medicaid, Marketplace, Essential Plan and other issues impacting hospitals' ability to provide care for patients. H.R. 5304 - Departments of Labor, Health and Human Services and Education and Regulated Agencies Appropriations - Issues related to agencies supporting health care research in the United States. S. 2587 - Departments of Labor, Health and Human Services and Education and Regulated Agencies Appropriations - Issues related to agencies supporting health care research in the United States. Policies, rules, and regulations related to Medicaid, Medicare, Essential and Marketplace coverage.
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: DAVITA INC. · Firm: RED+BLUE STRATEGIES
H.R. 1 - One Big Beautiful Bill Act - Issues related to Medicaid and other provisions impacting health care for people living with ESRD. H.R. 2199/S. 1173 - Restore Protections for Dialysis Patients Act - Issues related to Medicare Secondary Payer policies related to people with ESRD
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION (PCMA) · Firm: RED+BLUE STRATEGIES
H.R. 1 - The One Big Beautiful Bill Act - Issues related to pharmacy benefit managers and their role in the prescription medication supply chain. Issues related to pharmacy benefit managers and their role in public and private insurance coverage.
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION (PCMA) · Firm: RED+BLUE STRATEGIES
H.R. 1 - The One Big Beautiful Bill Act - Issues related to pharmacy benefit managers and their role in the prescription medication supply chain. Issues related to pharmacy benefit managers and their role in public and private insurance coverage.
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: CAREFIRST BLUECROSS BLUESHIELD · Firm: RED+BLUE STRATEGIES
H.R. 1 - One Big Beautiful Bill Act - Issues related to Medicaid, Marketplace and other policies impacting health care coverage. Regulatory issues related to Medicare Advantage. Regulatory issues related to the Maryland's CMS waiver.
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: MOUNT SINAI HOSPITALS GROUP, INC · Firm: RED+BLUE STRATEGIES
H.R. 1 - The One Big Beautiful Bill Act - Issues related to Medicaid, Marketplace, BHP and Medicare policies impacting hospitals and related health care institutions. H.R. 5304 - Departments of Labor, Health and Human Services and Education and Regulated Agencies Appropriations - Issues related to agencies supporting health care research in the United States. S. 2587 - Departments of Labor, Health and Human Services and Education and Regulated Agencies Appropriations - Issues related to agencies supporting health care research in the United States. Rules and regulations governing Medicare, Medicaid, Marketplace and other public insurance programs covering patient access to care.
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: AMERICAN HOSPITAL ASSOCIATION · Firm: RED+BLUE STRATEGIES
H.R. 1 - One Big Beautiful Bill Act - Issues related to Medicaid, Marketplace, Essential Plan and other issues impacting hospitals' ability to provide care for patients. Policies, rules, and regulations related to Medicaid, Medicare, Essential and Marketplace coverage.
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: DAVITA INC. · Firm: RED+BLUE STRATEGIES
H.R. 1 - One Big Beautiful Bill Act - Issues related to Medicaid and other provisions impacting health care for people living with ESRD. H.R. 2199/S. 1173 - Restore Protections for Dialysis Patients Act - Issues related to Medicare Secondary Payer policies related to people with ESRD
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: BAYCARE HEALTH SYSTEM · Firm: RED+BLUE STRATEGIES
H.R. 1 - One Big Beautiful Bill Act - Issues related to Medicaid and policies impacting patients, providers and hospitals. H.R. 5304 - Departments of Labor, Health and Human Services and Education and Regulated Agencies Appropriations - Issues related to agencies supporting health care research in the United States. S. 2587 - Departments of Labor, Health and Human Services and Education and Regulated Agencies Appropriations - Issues related to agencies supporting health care research in the United States. Issues related to the Medicare Hospital at Home program
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: AMERICAN HOSPITAL ASSOCIATION · Firm: RED+BLUE STRATEGIES
H.R. 1 - One Big Beautiful Bill Act - Issues related to Medicaid, Marketplace, Essential Plan and other issues impacting hospitals' ability to provide care for patients. Policies, rules, and regulations related to Medicaid, Medicare, Essential and Marketplace coverage.
Issues related to mental health, highlighting the clubhouse model of care.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
QUEST DIAGNOSTICS INCORPORATED via RED+BLUE STRATEGIES
2026 · third_quarter · Q3
Policies, rules, and regulations related to clinical laboratories and Medicare coverage policies. H.R.5269 - Reforming and Enhancing Sustainable Updates to Laboratory Testing Services (RESULTS) Act - Issues related to Medicare payments for lab tests. S.2761 - RESULTS Act - Issues related to Medicare payments for lab tests.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PRIME THERAPEUTICS via RED+BLUE STRATEGIES
2026 · third_quarter · Q3
Issues related to Pharmacy Benefit Managers and Medicare Part D.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION (PCMA) via RED+BLUE STRATEGIES
2026 · third_quarter · Q3
Issues related to pharmacy benefit managers and their role in public and private insurance coverage. Monitor issues and proposals related to health care price transparency.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PALANTIR TECHNOLOGIES, INC. via RED+BLUE STRATEGIES
2026 · third_quarter · Q3
Issues related to the FY27 Labor-HHS appropriations process - highlighting the One CDC Data Platform (1CDP).
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MOUNT SINAI HOSPITALS GROUP, INC via RED+BLUE STRATEGIES
2026 · third_quarter · Q3
Rules and regulations governing Medicare, Medicaid, Marketplace and other public insurance programs covering patient access to care. Issues related to the Essential Plan. Monitor issues and proposals related to health care price transparency. Monitor rulemaking related federal grants. Monitor issues related to AI in the health care space.
HR 7961 - Issues related to waiving the application fee for H-1B visas for foreign health care professionals seeking to work in the United States.
Rules and regulations governing Medicare, Medicaid, Marketplace and other public insurance programs covering patient access to care.
KAROO HEALTH via RED+BLUE STRATEGIES
2026 · third_quarter · Q3
Highlight the potential of innovative approaches for caring for cardiac patients.
Issues related to advancing innovative approaches to care for patients and their providers covered by public and private health insurance programs.
Issues related to advancing innovative approaches to care for patients and their providers covered by the Medicare and Medicaid programs.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
HPA MANAGEMENT GROUP INC. via RED+BLUE STRATEGIES
2026 · third_quarter · Q3
Issues related to technology to improve Medicaid outreach and enrollment. Issues related to the expansion of TrumpRx. Monitor issues related to maternal health.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
THE GUARDIAN LIFE INSURANCE COMPANY OF AMERICA via RED+BLUE STRATEGIES
2026 · third_quarter · Q3
H.R. 1397/S.1164 - Increasing Access to Dental Insurance Act of 2025 - Issues related to expanding access to quality dental care coverage to populations that require care. Regulatory issues impacting dental coverage issues in Medicare, Medicaid and Marketplace. H.R. 1521/S. 1424 (in 118th Congress - Senate reintroduction pending) - DOC Access Act - issues related to dental coverage.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
GREATER NEW YORK HOSPITAL ASSOCIATION via RED+BLUE STRATEGIES
2026 · third_quarter · Q3
Policies, rules, and regulations related to Medicaid, Medicare, Essential and Marketplace coverage. Issues related to the Essential Plan. Issues related to graduate medical education (GME) slots.
Policies, rules, and regulations related to Medicaid, Medicare, Essential and Marketplace coverage. Monitor issues related to 340B.
HR 7961 - Issues related to waiving the application fee for H-1B visas for foreign health care professionals seeking to work in the United States.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
GENEDX, LLC via RED+BLUE STRATEGIES
2026 · third_quarter · Q3
Issues related to tricare genetic testing.
H. R. 4709 - Newborn Screening Saves Lives Act of 2025 - Support for advancing 21st century genetic screenings protocols for newborns and their families. Issues related to access and affordability for pediatric genetic tests for children and families nationwide. H.R. 5269 - RESULTS Act - issues related to Medicare payments for lab tests. S. 2761 - RESULTS Act - issues related to Medicare payments for lab tests.
Issues related to access and affordability for pediatric genetic tests for families with Medicaid and Marketplace coverage. Issues related to the FY27 Labor-HHS appropriations process - highlighting Genetic Testing Guidance for State Medicaid Programs report language. H.R. 7118 - Genomic Answers for Children's Health Act of 2026 - support for clarifying access to genomic sequencing for children enrolled in Medicaid who have a suspected rare disease or genetic disorder.
GE HEALTHCARE via RED+BLUE STRATEGIES
2026 · third_quarter · Q3
Issues related to research and access to women's health screenings. Issues related to research and coverage of diagnostic procedures utilizing radiopharmaceuticals. Issues related to artificial intelligence and its role in the health care system.
Issues related to Veterans Affairs (VA) acquisition policy.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
DAVITA INC. via RED+BLUE STRATEGIES
2026 · third_quarter · Q3
H.R. 2199/S. 1173 - Restore Protections for Dialysis Patients Act - Issues related to Medicare Secondary Payer policies related to people with ESRD. Issues related to innovation-centered kidney care choices model. Issues related to hospice and dialysis.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
THE CIGNA GROUP via RED+BLUE STRATEGIES
2026 · third_quarter · Q3
Issues related to the health care marketplace and pharmacy benefit managers. Monitor issues related to Tricare pharmacy benefit.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CHILDREN'S HOSPITAL ASSOCIATION F/K/A NAT'L ASSOCIATION OF CHILDREN'S HOSPITALS via RED+BLUE STRATEGIES
2026 · third_quarter · Q3
Regulatory issues related to Medicaid and CHIP. Regulatory issues related to the Children's Hospitals Graduate Medical Education Program. Issues related to the FY27 Labor-HHS appropriations process - highlighting the Childrens Hospital Graduate Medical Education (CHGME) program and the Pediatric Specialty Loan Repayment Program. Issues related to CMS' State-Directed Payment Rule. Issues related to CMS' Inpatient Prospective Payment System (IPPS) Rule. Monitor rulemaking related federal grants.
Regulatory issues related to Medicaid and CHIP.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CHAPTER via RED+BLUE STRATEGIES
2026 · third_quarter · Q3
Issues related to technology to improve Medicare.gov. Issues related to Medicare brokers.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CAREFIRST BLUECROSS BLUESHIELD via RED+BLUE STRATEGIES
2026 · third_quarter · Q3
Regulatory issues related to Medicare Advantage. Regulatory issues related to the Maryland's CMS waiver and related CMMI models. Issues related to Marketplace coverage.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CAMBIA HEALTH SOLUTIONS (FORMERLY KNOWN AS THE REGENCE GROUP) via RED+BLUE STRATEGIES
2026 · third_quarter · Q3
Regulatory issues related to Medicare Advantage: Star Ratings.
Regulatory issues related to Medicare Advantage and the ACA Marketplace. Issues related to pharmacy benefit managers and their role in insurance coverage. Issues related to surprise medical billing.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BOSTON MEDICAL CENTER via RED+BLUE STRATEGIES
2026 · third_quarter · Q3
Regulatory issues related to Medicaid and CHIP. Monitor issues related to 340B, including H.R.9599 - SECURE 340B Act.
Regulatory issues related to ACA Marketplaces, Medicaid and CHIP. Regulatory issues related to health care research. H.R. 9260 - FY27 Depts. of Labor, HHS, Education Appropriations - and Senate FY27 Labor-HHS appropriations process - highlighting Hospital at Home report language.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BLUE CROSS BLUE SHIELD OF MASSACHUSETTS via RED+BLUE STRATEGIES
2026 · third_quarter · Q3
Regulatory issues related to Medicare Advantage and the ACA Marketplace.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BAYCARE HEALTH SYSTEM via RED+BLUE STRATEGIES
2026 · third_quarter · Q3
Issues related to the Medicare Hospital at Home program H.R.8923 - At HOME Services Act - issues related to hospital care at home Monitor issues and proposals related to health care price transparency Issues related to organ transplantation
Issues related to the Medicare Hospital at Home program. H.R. 9260 - FY27 Depts. of Labor, HHS, Education Appropriations - and Senate FY27 Labor-HHS appropriations process - highlighting Hospital at Home report language.
Monitor FY27 Commerce, Justice, Science, and Related Agencies bill.
ARCHER AVIATION via RED+BLUE STRATEGIES
2026 · third_quarter · Q3
Educate policy makers about eVTOL aircraft technology.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICAN HOSPITAL ASSOCIATION via RED+BLUE STRATEGIES
2026 · third_quarter · Q3
Policies, rules, and regulations related to Medicaid, Medicare, Essential and Marketplace coverage.
Policies, rules, and regulations related to Medicaid, Medicare, Essential and Marketplace coverage.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
HIMS&HERS via RED+BLUE STRATEGIES
2026 · third_quarter · RR
Issues related to compounding/telehealth/health care.
PRIME THERAPEUTICS via RED+BLUE STRATEGIES
2026 · third_quarter · RR
Issues related to Pharmacy Benefit Managers and Medicare Part D.
QUEST DIAGNOSTICS INCORPORATED via RED+BLUE STRATEGIES
2026 · second_quarter · Q2
Policies, rules, and regulations related to clinical laboratories and Medicare coverage policies. H.R.5269 - Reforming and Enhancing Sustainable Updates to Laboratory Testing Services (RESULTS) Act - Issues related to Medicare payments for lab tests. S.2761 - RESULTS Act - Issues related to Medicare payments for lab tests.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PALANTIR TECHNOLOGIES, INC. via RED+BLUE STRATEGIES
2026 · second_quarter · Q2
Issues related to the FY27 Labor-HHS appropriations process - highlighting the One CDC Data Platform (1CDP).
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
GREATER NEW YORK HOSPITAL ASSOCIATION via RED+BLUE STRATEGIES
2026 · second_quarter · Q2
Issues related to Federal Emergency Management Agency (FEMA) reimbursement for COVID-19 work.
HR 7961 - Issues related to waiving the application fee for H-1B visas for foreign health care professionals seeking to work in the United States
Policies, rules, and regulations related to Medicaid, Medicare, Essential and Marketplace coverage.
KAROO HEALTH via RED+BLUE STRATEGIES
2026 · second_quarter · Q2
Issues related to advancing innovative approaches to care for patients and their providers covered by public and private health insurance programs.
Issues related to advancing innovative approaches to care for patients and their providers covered by the Medicare and Medicaid programs.
Highlight the potential of innovative approaches for caring for cardiac patients.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
THE GUARDIAN LIFE INSURANCE COMPANY OF AMERICA via RED+BLUE STRATEGIES
2026 · second_quarter · Q2
H.R. 1397/S.1164 - Increasing Access to Dental Insurance Act of 2025 - Issues related to expanding access to quality dental care coverage to populations that require care. Regulatory issues impacting dental coverage issues in Medicare, Medicaid and Marketplace. H.R. 1521/S. 1424 (in 118th Congress - Senate reintroduction pending) - DOC Access Act - issues related to dental coverage.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
GENEDX, LLC via RED+BLUE STRATEGIES
2026 · second_quarter · Q2
Issues related to access and affordability for pediatric genetic tests for families with Medicaid and Marketplace coverage. Issues related to the FY27 Labor-HHS appropriations process - highlighting Genetic Testing Guidance for State Medicaid Programs report language. H.R. 7118 - Genomic Answers for Children's Health Act of 2026 - support for clarifying access to genomic sequencing for children enrolled in Medicaid who have a suspected rare disease or genetic disorder
H. R. 4709 - Newborn Screening Saves Lives Act of 2025 - Support for advancing 21st century genetic screenings protocols for newborns and their families. Issues related to access and affordability for pediatric genetic tests for children and families nationwide. H.R. 5269 - RESULTS Act - issues related to Medicare payments for lab tests. S. 2761 - RESULTS Act - issues related to Medicare payments for lab tests.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
DAVITA INC. via RED+BLUE STRATEGIES
2026 · second_quarter · Q2
H.R. 2199/S. 1173 - Restore Protections for Dialysis Patients Act - Issues related to Medicare Secondary Payer policies related to people with ESRD. Issues related to innovation-centered kidney care choices model. Exclusion of skin substitute spend from PY 2025 Comprehensive Kidney Care Contracting (CKCC) Kidney Care Entities (KCE) benchmarks.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
GE HEALTHCARE via RED+BLUE STRATEGIES
2026 · second_quarter · Q2
Issues related to Veterans Affairs (VA) acquisition policy
Issues related to research and access to women's health screenings. Issues related to research and coverage of diagnostic procedures utilizing radiopharmaceuticals. Issues related to artificial intelligence and its role in the health care system.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CAMBIA HEALTH SOLUTIONS (FORMERLY KNOWN AS THE REGENCE GROUP) via RED+BLUE STRATEGIES
2026 · second_quarter · Q2
Regulatory issues related to Medicare Advantage: Star Ratings.
Regulatory issues related to Medicare Advantage and the ACA Marketplace. Issues related to pharmacy benefit managers and their role in insurance coverage. Issues related to surprise medical billing.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BOSTON MEDICAL CENTER via RED+BLUE STRATEGIES
2026 · second_quarter · Q2
Regulatory issues related to ACA Marketplaces, Medicaid and CHIP. Regulatory issues related to health care research. H.R. 9260 - FY27 Depts. of Labor, HHS, Education Appropriations - and Senate FY27 Labor-HHS appropriations process - highlighting Hospital at Home report language.
Regulatory issues related to Medicaid and CHIP. Monitor issues related to 340B.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BLUE CROSS BLUE SHIELD OF MASSACHUSETTS via RED+BLUE STRATEGIES
2026 · second_quarter · Q2
Regulatory issues related to Medicare Advantage and the ACA Marketplace.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ARCHER AVIATION via RED+BLUE STRATEGIES
2026 · second_quarter · Q2
Educate policy makers about eVTOL aircraft technology.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
THE CIGNA GROUP via RED+BLUE STRATEGIES
2026 · second_quarter · Q2
Issues related to the health care marketplace and pharmacy benefit managers. Monitor issues related to Tricare pharmacy benefit.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICAN HOSPITAL ASSOCIATION via RED+BLUE STRATEGIES
2026 · second_quarter · Q2
Policies, rules, and regulations related to Medicaid, Medicare, Essential and Marketplace coverage.
Policies, rules, and regulations related to Medicaid, Medicare, Essential and Marketplace coverage. Monitoring H.R. 9504 - Tax Exempt Hospital Transparency Act - issues related to hospital reporting requirements.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CHAPTER via RED+BLUE STRATEGIES
2026 · second_quarter · Q2
Issues related to technology to improve Medicare.gov. Issues related to Medicare brokers.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Office of Management & Budget (OMB), SENATE
HPA MANAGEMENT GROUP INC. via RED+BLUE STRATEGIES
2026 · second_quarter · Q2
Issues related to technology to improve Medicaid outreach and enrollment. Issues related to the expansion of TrumpRx.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Office of Management & Budget (OMB), SENATE
MOUNT SINAI HOSPITALS GROUP, INC via RED+BLUE STRATEGIES
2026 · second_quarter · Q2
Rules and regulations governing Medicare, Medicaid, Marketplace and other public insurance programs covering patient access to care.
Rules and regulations governing Medicare, Medicaid, Marketplace and other public insurance programs covering patient access to care. Issues related to the Essential Plan. Monitoring H.R. 9504 - Tax Exempt Hospital Transparency Act - issues related to hospital reporting requirements Monitor issues and proposals related to health care price transparency
HR 7961 - Issues related to waiving the application fee for H-1B visas for foreign health care professionals seeking to work in the United States.
PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION (PCMA) via RED+BLUE STRATEGIES
2026 · second_quarter · Q2
Issues related to pharmacy benefit managers and their role in public and private insurance coverage. Monitor issues and proposals related to health care price transparency.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BAYCARE HEALTH SYSTEM via RED+BLUE STRATEGIES
2026 · second_quarter · Q2
Issues related to the Medicare Hospital at Home program. H.R. 9260 - FY27 Depts. of Labor, HHS, Education Appropriations - and Senate FY27 Labor-HHS appropriations process - highlighting Hospital at Home report language.
Monitor FY27 Commerce, Justice, Science, and Related Agencies bill
Issues related to the Medicare Hospital at Home program H.R.8923 - At HOME Services Act - issues related to hospital care at home Monitor issues and proposals related to health care price transparency Monitoring H.R. 9504 - Tax Exempt Hospital Transparency Act - issues related to hospital reporting requirements
CAREFIRST BLUECROSS BLUESHIELD via RED+BLUE STRATEGIES
2026 · second_quarter · Q2
Regulatory issues related to Medicare Advantage. Regulatory issues related to the Maryland's CMS waiver and related CMMI models. Issues related to Marketplace coverage.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CHILDREN'S HOSPITAL ASSOCIATION F/K/A NAT'L ASSOCIATION OF CHILDREN'S HOSPITALS via RED+BLUE STRATEGIES
2026 · second_quarter · Q2
Regulatory issues related to Medicaid and CHIP.
Regulatory issues related to Medicaid and CHIP. Regulatory issues related to the Children's Hospitals Graduate Medical Education Program. Issues related to the FY27 Labor-HHS appropriations process - highlighting the Childrens Hospital Graduate Medical Education (CHGME) program and the Pediatric Specialty Loan Repayment Program. Monitoring H.R. 9504 - Tax Exempt Hospital Transparency Act - issues related to hospital reporting requirements. Issues related to CMS' State-Directed Payment Rule. Issues related to CMS' Inpatient Prospective Payment System (IPPS) Rule.
Filing targets: HOUSE OF REPRESENTATIVES, Health Resources & Services Administration (HRSA), SENATE
FOUNTAIN HOUSE via RED+BLUE STRATEGIES
2026 · third_quarter · RR
Issues related to mental health, highlighting the clubhouse model of care.
CAREFIRST BLUECROSS BLUESHIELD via RED+BLUE STRATEGIES
2026 · first_quarter · Q1
Regulatory issues related to Medicare Advantage. Regulatory issues related to the Maryland's CMS waiver and related CMMI models. Issues related to the Enhanced APTCs for coverage in the health care Marketplace.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICAN HOSPITAL ASSOCIATION via RED+BLUE STRATEGIES
2026 · first_quarter · Q1
Policies, rules, and regulations related to Medicaid, Medicare, Essential and Marketplace coverage.
Policies, rules, and regulations related to Medicaid, Medicare, Essential and Marketplace coverage. Monitor proposals related to NIH's calculation of indirect costs.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BAYCARE HEALTH SYSTEM via RED+BLUE STRATEGIES
2026 · first_quarter · Q1
Issues related to the Medicare Hospital at Home program. Issues related to the FY27 Labor-HHS appropriations process - highlighting Hospital at Home report language.
Issues related to the Medicare Hospital at Home program. H.R.4313 - Hospital Inpatient Services Modernization Act - issues related to the hospital care at home. Monitor proposals related to NIH's calculation of indirect costs. H.R. 7148 - Consolidated Appropriations Act, 2026 - issues related to agencies supporting health care research in the U.S
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
ARCHER AVIATION via RED+BLUE STRATEGIES
2026 · first_quarter · Q1
Educate policy makers about eVTOL aircraft technology.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
DAVITA INC. via RED+BLUE STRATEGIES
2026 · first_quarter · Q1
H.R. 2199/S. 1173 - Restore Protections for Dialysis Patients Act - Issues related to Medicare Secondary Payer policies related to people with ESRD. Issues related to innovation-centered kidney care choices model. Exclusion of skin substitute spend from PY 2025 Comprehensive Kidney Care Contracting (CKCC) Kidney Care Entities (KCE) benchmarks.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
THE GUARDIAN LIFE INSURANCE COMPANY OF AMERICA via RED+BLUE STRATEGIES
2026 · first_quarter · Q1
H.R. 1397/S.1164 - Increasing Access to Dental Insurance Act of 2025 - Issues related to expanding access to quality dental care coverage to populations that require care. Regulatory issues impacting dental coverage issues in Medicare, Medicaid and Marketplace. H.R. 1521/S. 1424 (in 118th Congress - Senate reintroduction pending) - DOC Access Act - issues related to dental coverage.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
HPA MANAGEMENT GROUP INC. via RED+BLUE STRATEGIES
2026 · first_quarter · Q1
Issues related to technology to improve Medicaid outreach and enrollment.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
KAROO HEALTH via RED+BLUE STRATEGIES
2026 · first_quarter · Q1
Issues related to advancing innovative approaches to care for patients and their providers covered by public and private health insurance programs.
Issues related to advancing innovative approaches to care for patients and their providers covered by the Medicare and Medicaid programs.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BOSTON MEDICAL CENTER via RED+BLUE STRATEGIES
2026 · first_quarter · Q1
Regulatory issues related to Medicaid and CHIP. H.R. 7148 - Consolidated Appropriations Act, 2026 - issues related to agencies supporting health care research in the U.S.
Regulatory issues related to ACA Marketplaces, Medicaid and CHIP. Regulatory issues related to health care research. Monitor proposals relating to NIH's calculation of indirect costs. H.R. 7148 - Consolidated Appropriations Act, 2026 - issues related to agencies supporting health care research in the U.S.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CAMBIA HEALTH SOLUTIONS (FORMERLY KNOWN AS THE REGENCE GROUP) via RED+BLUE STRATEGIES
2026 · first_quarter · Q1
Regulatory issues related to Medicare Advantage and the ACA Marketplace. Issues related to the Enhanced APTCs for coverage in the health care Marketplace. Issues related to pharmacy benefit managers and their role in insurance coverage.
Regulatory issues related to Medicare Advantage: Star Ratings.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION (PCMA) via RED+BLUE STRATEGIES
2026 · first_quarter · Q1
Issues related to pharmacy benefit managers and their role in public and private insurance coverage. H.R. 7148 - Consolidated Appropriations Act, 2026 - issues related to pharmacy benefit managers.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CHILDREN'S HOSPITAL ASSOCIATION F/K/A NAT'L ASSOCIATION OF CHILDREN'S HOSPITALS via RED+BLUE STRATEGIES
2026 · first_quarter · Q1
Regulatory issues related to Medicaid and CHIP. Regulatory issues related to the Children's Hospitals Graduate Medical Education Program. Monitor proposals related to NIH's calculation of indirect costs. H.R. 7148 - Consolidated Appropriations Act, 2026 - issues related to funding of agencies and programs related to children's health care. Issues related to the FY27 Labor-HHS appropriations process - highlighting the Childrens Hospital Graduate Medical Education (CHGME) program and the Pediatric Specialty Loan Repayment Program.
Regulatory issues related to Medicaid and CHIP.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PALANTIR TECHNOLOGIES, INC. via RED+BLUE STRATEGIES
2026 · first_quarter · Q1
Issues related to the FY27 Labor-HHS appropriations process - highlighting the One CDC Data Platform (1CDP).
Educating policymakers about how Palantir's technology is supporting the U.S. Department of Agriculture's (USDA's) One Farmer, One File initiative.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CHAPTER via RED+BLUE STRATEGIES
2026 · first_quarter · Q1
Issues related to technology to improve Medicare.gov.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
QUEST DIAGNOSTICS INCORPORATED via RED+BLUE STRATEGIES
2026 · first_quarter · Q1
Policies, rules, and regulations related to clinical laboratories and Medicare coverage policies. H.R.5269 - Reforming and Enhancing Sustainable Updates to Laboratory Testing Services (RESULTS) Act - Issues related to Medicare payments for lab tests. S.2761 - RESULTS Act - Issues related to Medicare payments for lab tests. H.R. 7148 - Consolidated Appropriations Act, 2026 - issues related to clinical lab test reimbursement rates.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BLUE CROSS BLUE SHIELD OF MASSACHUSETTS via RED+BLUE STRATEGIES
2026 · first_quarter · Q1
Regulatory issues related to Medicare Advantage and the ACA Marketplace. Issues related to the Enhanced APTCs for coverage in the health care Marketplace.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
GE HEALTHCARE via RED+BLUE STRATEGIES
2026 · first_quarter · Q1
Issues related to research and access to women's health screenings. Issues related to research and coverage of diagnostic procedures utilizing radiopharmaceuticals. Issues related to artificial intelligence and its role in the health care system. Monitor proposals related to NIH's calculation of indirect costs.
Issues related to Veterans Affairs (VA) acquisition policy
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
GENEDX, LLC via RED+BLUE STRATEGIES
2026 · first_quarter · Q1
H. R. 4709 - Newborn Screening Saves Lives Act of 2025 - Support for advancing 21st century genetic screenings protocols for newborns and their families. Issues related to access and affordability for pediatric genetic tests for children and families nationwide.
Issues related to access and affordability for pediatric genetic tests for families with Medicaid and Marketplace coverage. Issues related to the FY27 Labor-HHS appropriations process - highlighting Genetic Testing Guidance for State Medicaid Programs report language. H.R. 7118 - Genomic Answers for Children's Health Act of 2026 - support for clarifying access to genomic sequencing for children enrolled in Medicaid who have a suspected rare disease or genetic disorder
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
GREATER NEW YORK HOSPITAL ASSOCIATION via RED+BLUE STRATEGIES
2026 · first_quarter · Q1
HR 7961 - Issues related to waiving the application fee for H-1B visas for foreign health care professionals seeking to work in the United States
Policies, rules, and regulations related to Medicaid, Medicare, Essential and Marketplace coverage. Issues related to the Essential Plan. Monitor proposals related to NIH's calculation of indirect costs. Issues related to graduate medical education (GME) slots. H.R. 7148 - Consolidated Appropriations Act, 2026 - issues related to agencies supporting health care research in the U.S.
Issues related to Federal Emergency Management Agency (FEMA) reimbursement for COVID-19 work.
MOUNT SINAI HOSPITALS GROUP, INC via RED+BLUE STRATEGIES
2026 · first_quarter · Q1
Rules and regulations governing Medicare, Medicaid, Marketplace and other public insurance programs covering patient access to care. Issues related to the Essential Plan. Monitor proposals related to NIH's calculation of indirect costs. H.R. 7148 - Consolidated Appropriations Act, 2026 - issues related to agencies supporting health care research in the U.S. Issues related to Federally Qualified Health Centers (FQHCs).
Rules and regulations governing Medicare, Medicaid, Marketplace and other public insurance programs covering patient access to care.
HR 7961 - Issues related to waiving the application fee for H-1B visas for foreign health care professionals seeking to work in the United States.
CHAPTER via RED+BLUE STRATEGIES
2026 · first_quarter · RR
Issues related to technology to improve Medicare.gov
PALANTIR TECHNOLOGIES, INC. via RED+BLUE STRATEGIES
2026 · first_quarter · RR
Software and technology procurement and federal funding.
Software and technology procurement and federal funding.
THE CIGNA GROUP via RED+BLUE STRATEGIES
2026 · second_quarter · RR
Issues related to pharmacy benefit management services, pharmacy, specialty pharmacy, and individual and group health insurance markets.
CAREFIRST BLUECROSS BLUESHIELD via RED+BLUE STRATEGIES
2025 · fourth_quarter · Q4
Regulatory issues related to Medicare Advantage. Regulatory issues related to the Maryland's CMS waiver and related CMMI models. Issues related to the Enhanced APTCs for coverage in the health care Marketplace.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BOSTON MEDICAL CENTER via RED+BLUE STRATEGIES
2025 · fourth_quarter · Q4
H.R. 5304 - Departments of Labor, Health and Human Services and Education and Regulated Agencies Appropriations - Issues related to agencies supporting health care research in the United States. S. 2587 - Departments of Labor, Health and Human Services and Education and Regulated Agencies Appropriations - Issues related to agencies supporting health care research in the United States. Regulatory issues related to ACA Marketplaces, Medicaid and CHIP. Regulatory issues related to health care research. Monitor proposals relating to NIH's calculation of indirect costs.
H.R. 5304 - Departments of Labor, Health and Human Services and Education and Regulated Agencies Appropriations - Issues related to agencies supporting health care research in the United States. S. 2587 - Departments of Labor, Health and Human Services and Education and Regulated Agencies Appropriations - Issues related to agencies supporting health care research in the United States. Regulatory issues related to Medicaid and CHIP.
BLUE CROSS BLUE SHIELD OF MASSACHUSETTS via RED+BLUE STRATEGIES
2025 · fourth_quarter · Q4
Regulatory issues related to Medicare Advantage and the ACA Marketplace. Issues related to the Enhanced APTCs for coverage in the health care Marketplace.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
ARCHER AVIATION via RED+BLUE STRATEGIES
2025 · fourth_quarter · Q4
Educate policy makers about eVTOL aircraft technology.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICAN HOSPITAL ASSOCIATION via RED+BLUE STRATEGIES
2025 · fourth_quarter · Q4
Policies, rules, and regulations related to Medicaid, Medicare, Essential and Marketplace coverage. Monitor proposals related to NIH's calculation of indirect costs.
Policies, rules, and regulations related to Medicaid, Medicare, Essential and Marketplace coverage.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CHILDREN'S HOSPITAL ASSOCIATION F/K/A NAT'L ASSOCIATION OF CHILDREN'S HOSPITALS via RED+BLUE STRATEGIES
2025 · fourth_quarter · Q4
H.R. 5304 - Departments of Health and Human Services and Education and Related Agencies Appropriations Act of 2025-26 - Issues related to funding of agencies and programs related to children's health care. S. 2587 - Departments of Health and Human Services and Education and Related Agencies Appropriations Act of 2025-26 - Issues related to funding of agencies and programs related to children's health care. Regulatory issues related to Medicaid and CHIP. Regulatory issues related to the Children's Hospitals Graduate Medical Education Program. Monitor proposals related to NIH's calculation of indirect costs.
Regulatory issues related to Medicaid and CHIP.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MOUNT SINAI HOSPITALS GROUP, INC via RED+BLUE STRATEGIES
2025 · fourth_quarter · Q4
Rules and regulations governing Medicare, Medicaid, Marketplace and other public insurance programs covering patient access to care.
H.R. 5304 - Departments of Labor, Health and Human Services and Education and Regulated Agencies Appropriations - Issues related to agencies supporting health care research in the United States. S. 2587 - Departments of Labor, Health and Human Services and Education and Regulated Agencies Appropriations - Issues related to agencies supporting health care research in the United States. Rules and regulations governing Medicare, Medicaid, Marketplace and other public insurance programs covering patient access to care. Issues related to the Essential Plan. Monitor proposals related to NIH's calculation of indirect costs.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
HPA MANAGEMENT GROUP INC. via RED+BLUE STRATEGIES
2025 · fourth_quarter · Q4
Issues related to technology to improve Medicaid outreach and enrollment.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
THE GUARDIAN LIFE INSURANCE COMPANY OF AMERICA via RED+BLUE STRATEGIES
2025 · fourth_quarter · Q4
H.R. 1397/S.1164 - Increasing Access to Dental Insurance Act of 2025 - Issues related to expanding access to quality dental care coverage to populations that require care. Regulatory issues impacting dental coverage issues in Medicare, Medicaid and Marketplace.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
GENEDX, LLC via RED+BLUE STRATEGIES
2025 · fourth_quarter · Q4
H. R. 4709 - Newborn Screening Saves Lives Act of 2025 - Support for advancing 21st century genetic screenings protocols for newborns and their families. Issues related to access and affordability for pediatric genetic tests for children and families nationwide.
Issues related to access and affordability for pediatric genetic tests for families with Medicaid and Marketplace coverage.
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
DAVITA INC. via RED+BLUE STRATEGIES
2025 · fourth_quarter · Q4
H.R. 2199/S. 1173 - Restore Protections for Dialysis Patients Act - Issues related to Medicare Secondary Payer policies related to people with ESRD. Issues related to innovation-centered kidney care choices model.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
COMMUNITY CATALYST via RED+BLUE STRATEGIES
2025 · fourth_quarter · 4T
Regulatory issues related to Medicaid and CHIP. Legislative and Regulatory issues related to medical debt. Issues related to shoring up Medicaid and Marketplace coverage for families.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CAMBIA HEALTH SOLUTIONS (FORMERLY KNOWN AS THE REGENCE GROUP) via RED+BLUE STRATEGIES
2025 · fourth_quarter · Q4
Affordable Care Act and Extending Enhanced APTCs (H.R. 247; S. 46, H.R. 6703), Fraudulent Enrollments in Qualified Health Plans (S. 976, HR 2079), Behavioral Health, Employer-Provided Health Coverage; Surprise Billing (S. 2420, S. 5535, H.R. 4710); Cybersecurity; Health IT, Health Care Innovation, Transparency & PBMs (S. 891, HR 6703), Prescription Drugs (S. 1954, S. 1096, S. 1096, S.1040) Price Transparency (S. 2355), Prior Authorization.
Medicare Advantage: Star Ratings, Risk Adjustment, Excellent Health Outcomes for All, Supplemental Benefits (H.R. 5746), No UPCODE Act (S. 1105), Medicare Prior Authorization and Electronic Prior Authorization, Provider Directories (S. 891), Telehealth Extending Flexibilities (H.R. 4206, S. 1261), Transparency & PBMs (S. 882; S. 891, S. 3345), Physician Fee Schedule, Site Neutrality (S. 1869 from 118th, H.R. 3417 from 118th).
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
GE HEALTHCARE via RED+BLUE STRATEGIES
2025 · fourth_quarter · Q4
Issues related to research and access to women's health screenings. Issues related to research and coverage of diagnostic procedures utilizing radiopharmaceuticals. Issues related to artificial intelligence and its role in the health care system. Monitor proposals related to NIH's calculation of indirect costs.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
GREATER NEW YORK HOSPITAL ASSOCIATION via RED+BLUE STRATEGIES
2025 · fourth_quarter · Q4
H.R. 5304 - Departments of Labor, Health and Human Services and Education and Regulated Agencies Appropriations - Issues related to agencies supporting health care research in the United States. S. 2587 - Departments of Labor, Health and Human Services and Education and Regulated Agencies Appropriations - Issues related to agencies supporting health care research in the United States. Policies, rules, and regulations related to Medicaid, Medicare, Essential and Marketplace coverage. Issues related to the Essential Plan. Monitor proposals related to NIH's calculation of indirect costs. Issues related to graduate medical education (GME) slots.
Policies, rules, and regulations related to Medicaid, Medicare, Essential and Marketplace coverage.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
QUEST DIAGNOSTICS INCORPORATED via RED+BLUE STRATEGIES
2025 · fourth_quarter · Q4
Policies, rules, and regulations related to clinical laboratories and Medicare coverage policies. H.R.5269 - Reforming and Enhancing Sustainable Updates to Laboratory Testing Services (RESULTS) Act - Issues related to Medicare payments for lab tests. S.2761 - RESULTS Act - Issues related to Medicare payments for lab tests.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BAYCARE HEALTH SYSTEM via RED+BLUE STRATEGIES
2025 · fourth_quarter · Q4
H.R. 5304 - Departments of Labor, Health and Human Services and Education and Regulated Agencies Appropriations - Issues related to agencies supporting health care research in the United States. Issues related to the Medicare Hospital at Home program. H.R.4313 - Hospital Inpatient Services Modernization Act - issues related to the hospital care at home. Monitor proposals related to NIH's calculation of indirect costs. S. 2587 - Departments of Labor, Health and Human Services and Education and Regulated Agencies Appropriations - Issues related to agencies supporting health care research in the United States.
Issues related to the Medicare Hospital at Home program.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
KAROO HEALTH via RED+BLUE STRATEGIES
2025 · fourth_quarter · Q4
Issues related to advancing innovative approaches to care for patients and their providers covered by public and private health insurance programs.
Issues related to advancing innovative approaches to care for patients and their providers covered by the Medicare and Medicaid programs.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION (PCMA) via RED+BLUE STRATEGIES
2025 · fourth_quarter · Q4
Issues related to pharmacy benefit managers and their role in public and private insurance coverage.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICAN HOSPITAL ASSOCIATION via RED+BLUE STRATEGIES
2025 · third_quarter · Q3
H.R. 1 - One Big Beautiful Bill Act - Issues related to Medicaid, Marketplace, Essential Plan and other issues impacting hospitals' ability to provide care for patients. Policies, rules, and regulations related to Medicaid, Medicare, Essential and Marketplace coverage.
H.R. 1 - One Big Beautiful Bill Act - Issues related to Medicaid, Marketplace, Essential Plan and other issues impacting hospitals' ability to provide care for patients. Policies, rules, and regulations related to Medicaid, Medicare, Essential and Marketplace coverage.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
KAROO HEALTH via RED+BLUE STRATEGIES
2025 · third_quarter · Q3
Issues related to advancing innovative approaches to care for patients and their providers covered by public and private health insurance programs.
Issues related to advancing innovative approaches to care for patients and their providers covered by the Medicare and Medicaid programs.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
HPA MANAGEMENT GROUP INC. via RED+BLUE STRATEGIES
2025 · third_quarter · Q3
Issues related to technology to improve Medicaid outreach and enrollment.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MOUNT SINAI HOSPITALS GROUP, INC via RED+BLUE STRATEGIES
2025 · third_quarter · Q3
H.R. 1 - The One Big Beautiful Bill Act - Issues related to Medicaid, Marketplace, BHP and Medicare policies impacting hospitals and related health care institutions. H.R. 5304 - Departments of Labor, Health and Human Services and Education and Regulated Agencies Appropriations - Issues related to agencies supporting health care research in the United States. S. 2587 - Departments of Labor, Health and Human Services and Education and Regulated Agencies Appropriations - Issues related to agencies supporting health care research in the United States. Rules and regulations governing Medicare, Medicaid, Marketplace and other public insurance programs covering patient access to care.
H.R. 1 - The One Big Beautiful Bill Act - Issues related to Medicaid, Marketplace, BHP and Medicare policies impacting hospitals and related health care institutions. Rules and regulations governing Medicare, Medicaid, Marketplace and other public insurance programs covering patient access to care.
ARCHER AVIATION via RED+BLUE STRATEGIES
2025 · third_quarter · Q3
Educate policy makers about eVTOL aircraft technology. Issues related to NASA programming
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
GENEDX, LLC via RED+BLUE STRATEGIES
2025 · third_quarter · Q3
H.R. 1 - The One Big Beautiful Bill Act - Issues realted to pediatric screening and testing. H. R. 4709 - Newborn Screening Saves Lives Act of 2025 - Support for advancing 21st century genetic screenings protocols for newborns and their families. Issues related to access and affordability for pediatric genetic tests for children and families nationwide.
H.R. 1 - The One Big Beautiful Bill Act - Issues realted to pediatric screening and testing. Issues related to access and affordability for pediatric genetic tests for families with Medicaid and Marketplace coverage.
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
GREATER NEW YORK HOSPITAL ASSOCIATION via RED+BLUE STRATEGIES
2025 · third_quarter · Q3
H.R. 1 - One Big Beautiful Bill Act - Issues related to Medicaid, Marketplace, Essential Plan and other issues impacting hospitals' ability to provide care for patients. H.R. 5304 - Departments of Labor, Health and Human Services and Education and Regulated Agencies Appropriations - Issues related to agencies supporting health care research in the United States. S. 2587 - Departments of Labor, Health and Human Services and Education and Regulated Agencies Appropriations - Issues related to agencies supporting health care research in the United States. Policies, rules, and regulations related to Medicaid, Medicare, Essential and Marketplace coverage.
H.R. 1 - One Big Beautiful Bill Act - Issues related to Medicaid, Marketplace, Essential Plan and other issues impacting hospitals' ability to provide care for patients. Policies, rules, and regulations related to Medicaid, Medicare, Essential and Marketplace coverage.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BAYCARE HEALTH SYSTEM via RED+BLUE STRATEGIES
2025 · third_quarter · Q3
H.R. 1 - One Big Beautiful Bill Act - Issues related to Medicaid and policies impacting patients, providers and hospitals. H.R. 5304 - Departments of Labor, Health and Human Services and Education and Regulated Agencies Appropriations - Issues related to agencies supporting health care research in the United States. S. 2587 - Departments of Labor, Health and Human Services and Education and Regulated Agencies Appropriations - Issues related to agencies supporting health care research in the United States. Issues related to the Medicare Hospital at Home program
H.R. 1 - One Big Beautiful Bill Act - Issues related to Medicaid and policies impacting patients, providers and hospitals. Issues related to the Medicare Hospital at Home program
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
QUEST DIAGNOSTICS INCORPORATED via RED+BLUE STRATEGIES
2025 · third_quarter · Q3
H.R. 1 - One Big Beautiful Bill Act - Issues related to Medicaid and other provisions impacting access to laboratory services for covered populations. Policies, rules, and regulations related to clinical laboratories and Medicare coverage policies.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
THE GUARDIAN LIFE INSURANCE COMPANY OF AMERICA via RED+BLUE STRATEGIES
2025 · third_quarter · Q3
H.R. 1 - One Big Beautiful Bill Act - Issues related to Medicaid and Marketplace coverage and polices focused on paid leave. H.R. 1397/S.1164 - Increasing Access to Dental Insurance Act of 2025 - Issues related to expanding access to quality dental care coverage to populations that require care. Regulatory issues impacting dental coverage issues in Medicare, Medicaid and Marketplace
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Filing targets: HOUSE OF REPRESENTATIVES, Health Resources & Services Administration (HRSA), SENATE
Policies, rules, and regulations related to Medicaid, Medicare, Essential and Marketplace coverage. Issues related to the Essential Plan. Issues related to graduate medical education (GME) slots. Monitoring H.R. 9504 - Tax Exempt Hospital Transparency Act - issues related to hospital reporting requirements.
Filing targets: HOUSE OF REPRESENTATIVES, Homeland Security, Dept of (DHS), SENATE
Issues related to Federal Emergency Management Agency (FEMA) reimbursement for COVID-19 work.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
Policies, rules, and regulations related to Medicaid, Medicare, Essential and Marketplace coverage.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Issues related to Federal Emergency Management Agency (FEMA) reimbursement for COVID-19 work.
Filing targets: HOUSE OF REPRESENTATIVES, Health Resources & Services Administration (HRSA), SENATE
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Filing targets: HOUSE OF REPRESENTATIVES, SENATE